[{"id":"50a0dee6-dba1-4ab6-a74f-43429223178c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05976906","created_at":"2023-08-04T17:10:04.308Z","updated_at":"2024-07-02T16:35:40.929Z","phase":"Phase 1","brief_title":"Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors","source_id_and_acronym":"NCT05976906","lead_sponsor":"Zhejiang University","biomarkers":" IL2","pipe":"","alterations":" ","tags":["IL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CNK-UT"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 05/23/2023","start_date":" 05/23/2023","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 09/01/2025","study_completion_date":" 09/01/2025","last_update_posted":"2023-08-04"}]